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Abstract  
 
Background 
 
Few studies have tried to assess the combined cross-sectional and temporal contributions of 
a more comprehensive set of amenable factors to population health outcomes for wealthy 
countries during the last 30 years of the 20th century. We assessed the overall ecological 
associations between mortality and factors amenable to public health. These amenable 
factors included addictive and nutritional lifestyle, air quality, public health spending, 
healthcare coverage, and immunizations. 
 
Methods 
 
We used a pooled cross-sectional, time series analysis with corrected fixed effects regression 
models in an ecological design involving eighteen member countries of the Organisation for 
Economic Cooperation and Development during the period 1970 to 1999. 
 
Results 
 
Alcohol, tobacco, and fat consumption, and sometimes, air pollution were significantly 
associated with higher all-cause mortality and premature death. Immunizations, health care 
coverage, fruit/vegetable and protein consumption, and collective health expenditure had 
negative effects on mortality and premature death, even after controlling for the elderly, 
density of practicing physicians, doctor visits and per capita GDP. However, tobacco, air 
pollution, and fruit/vegetable intake were sometimes sensitive to adjustments. 
 
Conclusion 
 
Mortality and premature deaths could be improved by focusing on factors that are amenable 
to public health policies. Tackling these issues should be reflected in the ongoing 
assessments of health system performance. 
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Background  
 
Western populations currently enjoy unprecedented wealth and longevity [1]. It is held that 
medical care – or more broadly healthcare including public health – contributed immensely to 
the increased longevity. However, McKeown [2], McKinlay et al [3,4], Illich [5] and others have 
questioned the role of medical care in these gains. Others, like Mackenbach [6,7] and Bunker 
et al [8,9] contend that medical care has contributed reasonably to the mortality decline. 
Unfortunately, these debates have done little to further the course and relevance of health 
systems today. Resource constraints, poor quality, and the controversial World Health Report 
2000 [10] have all led to the increased assessment of health systems in terms of 
effectiveness [11], safety [12], equity and responsiveness [10]. Meanwhile, the functioning of 
the public health aspect of health systems has received less attention. Functional public 
health systems are nowadays seen within the context of health promotion and integral social 
structures [13]. This focus on health promotion strategies that are embedded in societal 
structures has been described as public health coming "full circle" in the "new public health" 
era [14]. 
 
The new public health hopes to address major risk factors implicated in the global burden of 
disease. These factors, which threaten the substantial health gains made in the 20th century, 
include addictive behavior (such as tobacco smoking), nutritional lifestyle (e.g. fat 
consumption), degrading environmental quality (e.g. air pollution), and less-than-adequate 
public health investments, coverage and preventive interventions (e.g. immunizations) [15]. 
Despite the recent increase in studies that either looked primarily at such factors or controlled 
for them in their analyses [16-22], few studies have tried to assess the combined cross-
sectional and temporal contributions of a more comprehensive set of amenable factors to 
population health outcomes for wealthy countries during the last 30 years of the 20th century. 
 
Therefore, this study uses a pooled, cross-country time-series design to assess the ecological 
relationships of such amenable factors to population health, adjusting for demographic, 
national wealth, and medical care-related factors in selected industrialized countries during 
the period 1970–1999. Population health is a commonly used compound indicator of health 
system and social performance, and is captured in this study as all-cause mortality and all-
cause potential years of life lost. We aim to speak to the relevance of public health-related 
issues, and their place in assessing health system performance. 
 
Theoretical framework 
 
Public Health, as an organized effort of society [23], espouses several principles, namely: (a) 
emphasis on collective responsibility and role of the state; (b) focus on whole populations; (c) 
emphasis on prevention; (d) concern for the underlying socio-economic determinants of 
health and disease; (e) multi-disciplinary approach (both quantitatively and qualitatively); and 
(f) partnerships with populations served [24]. These principles form a useful basis for 
evaluating the functioning of public health systems [25]. Simply put, medical care (with its 
emphasis on personal clinical services) and public health (with its emphasis on collective 
societal efforts for population health) represent the two traditional components of a health 
system [26]. 
 
Given public health's broad focus on population health, the theoretical framework for this 
study is based on a population health determinants model [27-31]. There are many 
determinants of population health which are commonly classified as either proximal or distal 
[18]. The proximal determinants have direct effects on health, and the distal determinants 
have indirect effects. 
 
The proximal determinants, which act on both micro and macro levels, often include lifestyle 
or behavior (e.g. alcohol, fat, tobacco, fruit and vegetable consumption), and socioeconomic 
environment (including macro-economic measures such as wealth), demography (e.g. elderly 
proportion of the total population), physical environment (e.g. air pollution by oxides of 
sulphur, nitrogen or carbon) and host constitution. The health system, which also operates at 
this proximal level, shares an interface with other sectors of organized societies such as the 
social, political and economic systems. Health system inputs such as physicians and medical 
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technology may be the result of intersectoral dynamics and social choices [32]. It is expected 
that public health systems can influence many of the proximal non-medical determinants and 
avert or minimize the need for expensive medical care. 
 
Distal determinants of health include the national, institutional, political, legal, and cultural 
factors that indirectly influence health by acting on the more proximal factors, their interrelated 
mechanisms, levels, trends, and distributions. These distal factors are usually more stable 
than proximal determinants. Though we do not address distal factors in this study, we can 
roughly capture their potential impact on mortality over time by using dummy variables to 
account for any unmeasured time-dependent heterogeneity introduced by these distal 
determinants. 
 
Methods  
 
We use an ecological design – a pooled cross-sectional, time series analysis of secondary 
data [33,34] – to quantify the relationship between average population health and factors 
amenable to public health, taking into account demographic, medical, and macro-economic 
(that is, crude national wealth) determinants of health. The analysis is based on the country-
year units of selected eighteen member countries of the Organisation of Economic 
Cooperation and Development (OECD) from 1970 to 1999. 
 
Data and measures 
 
The data for this study are derived from secondary sources [35,36]. The eighteen countries 
are a convenient sample of wealthy societies whose health experiences are different enough 
to allow for variation, but similar enough to support effective pooling. These countries, which 
were used in a recent study on primary care and mortality, are Australia, Belgium, Canada, 
Denmark, Finland, France, Germany, Greece, Italy, Japan, the Netherlands, Norway, 
Portugal, Spain, Sweden, Switzerland, the United Kingdom, and the United States [18]. The 
data management and preparation follow the methods used in that study [18]. 
 
The outcome measures of health system performance used are age- and sex-standardized 
all-cause total mortality, and potential years of life lost (PYLL) from all-causes. Both types of 
measures, expressed per 100,000 population, are standardized to the 1980 OECD 
population. The all-cause PYLL is a measure of premature, but preventable death before age 
70 years. PYLL is calculated by summing up deaths occurring at each age and multiplying 
this with the number of remaining years to live up to the selected 70-year limit. Both all-cause 
mortality and PYLL have been used in ecological studies of health outcomes [18,37,38]. 
 
The independent measures represent four convenient blocks of amenable factors: addictive 
behavior/lifestyle; nutritional lifestyle; environment, investment and coverage; and disease 
preventive measures. Alcohol (measured in liters per capita) and tobacco (in grams per 
capita) consumption represent the commoner addictive lifestyle factors used in studies [18]. 
Consumptions of fat, fruit/vegetable (both in kilograms per capita), and protein (measured in 
grams per capita per day) reflect nutritional lifestyle. The OECD data on nutritional factors 
come from the FAOSTAT database of the Food and Agriculture Organization of the United 
Nations [39]. 
 
Air pollution is measured as the emission of nitrogen oxide in kilograms per capita, and is 
expected to have negative effects on health and the environment [40]. Collective (public) 
health expenditure is a measure of national expenditure on prevention, public health services 
and health administration (excluding medical or personal care expenditure), and is 
hypothesized to have a negative effect on mortality. We quantified collective expenditure as a 
percentage of GDP to reduce collinearity. Although already at high levels in the selected 
OECD countries, healthcare coverage is a good structural variable for the percentage of the 
total population that can access public healthcare goods and services included in total public 
health expenditure, independent of the scope of cost sharing. Here, air pollution, collective 
health expenditure, and healthcare coverage represent the environment, public health 
investment and coverage. 
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Percentages of children reaching their first birthday who were immunized against measles 
and DTP (diphtheria, tetanus and pertussis) are used as measures of preventive functions of 
public health, though they could also serve as outcomes. However, we used two dummy 
variables to control for 1980s and 1990s fixed effects, and omitted variable bias and to 
eliminate any unobserved heterogeneity [34]. The 1970s served as reference. 
 
To account for demographic, medical care, and macro-economic factors, we chose several 
well-documented measures. These were: percentage of the total population aged 65 year and 
above as a demographic measure (elderly); practicing physician density per 1,000 population 
and per capita doctor visits as measures of medical care input; and population standardized 
gross domestic product (GDP per capita) as a measure of national wealth and a proxy for 
medical expenditures [18]. We deflated the GDP per capita by using the constant 1995 US 
dollar. 
 
Design and analysis 
 
We employed a pooled cross-sectional time series design that entailed stacking the eighteen 
countries (also referred to as cross-sections) over time. This resulted in a combination of 
cross-sections and time series with a matrix configuration that considered variation between 
cross-sections before variation within cross-sections over time. The obvious advantage of 
using a pooled ecological design is that it increases statistical power. We used fixed effects 
regression models and robust statistical modeling techniques to overcome repeated measure 
biases, correlated errors and heterogeneity [41-44]. The final regression model is specified as 
follows: 
 
Ynt = t + 0 + kXknt + nt 
 
where 
 
n = 1....18 countries 
 
t = 1....T time points (calendar years from 1970 through 1999) 
 
k = 1....K number of independent variables 
 
t = set of time effect dummy variable(s) 
 
0 = constant 
 
k = pooled regression estimates of the effect of each independent variable 
 
Xknt = independent variables per country for each unit year 
 
Unfortunately, simply because the above regression equation includes both stochastic and 
non-stochastic variables, the expected value of the error term is not zero and the variance is 
not constant. By assuming all the coefficients (the k's) to be the same for each cross-section 
within the regression model, we compound the problems of heteroscedasticity (that is, non-
constant variances) or autoregression (that is, decaying variance due to correlated error 
terms over time). Autoregression can only be addressed after heteroscedasticity has been 
corrected for, since both anomalies cannot be visualized at the same time [33]. For pooled 
data with correlated errors, the ordinary least squares (OLS) method does not yield the 
correct standard errors on which to base the hypothesis or relationship testing under study. 
To correct for heteroscedasticity in this sample, we employ heteroscedasticity-consistent 
standard error (HCSE) estimators which use the square of the residuals from the OLS 
equation to approximate the variance-covariance structure of the regression estimates [41-
44]. Since most of these estimators have not been fully implemented in routine statistical 
software packages, we use a special HCSE macro to model the heteroscedasticity-consistent 
covariance matrix [44]. Autoregression is then addressed via a quasi-differencing technique 
[34]. 
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Alternatively, the pooled cross-sectional time series data could be treated as repeated 
observations on each cross-section, although strictly speaking, here, they represent average 
national characteristics per unit time [34]. Similar results are obtained for this study by using 
the Linear Mixed Models procedure of SPSS (version 12.0.2, SPSS Inc., IL, March 2004) and 
the SAS PROC MIXED (version 8.2, SAS Institute Inc, NC, 2001) procedure to model the 
means, variances and covariances of this data as repeated measures. However, these 
general softwares implement a heteroskedastic-consistent matrix method which uses 
conditional variance of the error, rather than the more robust methods which we used to 
adjust each squared residual by a function of how deviant the pattern of independent 
variables of each cross-section is [43]. 
 
We used five pre-specified nested models to address the question 'after adjusting for 
demographic, medical care input, and wealth, can mortality and premature death be still 
explained by factors amenable to public health?' The first four models used measures of 
addictive behavior/lifestyle; nutritional lifestyle; environment, investment and coverage; and 
preventive measures. Model 1 examined the effects of tobacco and alcohol on mortality. 
Model 2 extended model 1 to include fat, fruit/vegetable and protein consumption. Model 3 
added air pollution, collective health expenditure, and health care coverage. In model 4, we 
included measles and DTP immunizations. Finally, model 5 further adjusted for time fixed 
effects using per decade time dummies with the first decade (1970s) as reference [34]. We 
also re-estimated models 3 to 5 after excluding the United States from the healthcare 
coverage variable, given the known lower levels of healthcare coverage in the American 
population. In addition, we re-ran these models excluding the healthcare coverage variable 
entirely in order to gauge its impact on the models considering that healthcare coverage also 
reflects access to care in general, not just public health services. We present statistics for 
hypothesis testing, model improvement and the proportion of total variance (as adjusted R 
squared) in outcomes explained in the final models, along with the regression estimates and 
their modeled standard errors. 
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Results  
 
Table 1 
 
Descriptive statistics for variables used in the pooled cross-sectional time series 
analysis 
 
Variables 1970–79 1980–89 1990–99 
 
 
 Mean Standard 
deviation 
Mean Standard 
deviation 
Mean Standard 
deviation 
 
All-cause mortality (both sexes per 
100,000 population) 
938.25 113.74 789.11 79.79 687.65 83.87 
Potential years of life lost (before age 
70 years per 100,000 population) 
7009.15 1449.67 5372.07 891.38 4424.51 798.37 
Tobacco (grams per capita) 2,699.88 450.32 2411.38 455.98 2052.00 502.29 
Alcohol consumption (liters per 
capita) 
11.62 3.52 11.33 2.94 9.98 2.27 
Fat consumption (kilograms of butter 
per capita per year) 
5.42 3.76 4.90 3.30 3.56 2.42 
Fruit & vegetable consumption 
(kilograms per capita per year) 
184.69 61.97 200.14 68.71 220.75 71.03 
Protein consumption (grams per 
capita per day) 
93.48 8.03 98.62 7.81 103.06 7.52 
Pollution (Nitrogen oxide emission, in 
kilograms per capita) 
41.50 16.29 43.77 20.72 44.71 26.59 
Collective health expenditure (% 
GDP) 
0.45 0.24 0.50 0.25 0.53 0.32 
Healthcare coverage (% population) 
[without USA] 
90.49 
[92.2] 
13.69 [12.10] 94.16 
[96.75] 
13.40 [7.10] 93.84 
[97.86] 
17.61 [5.96] 
DTP immunization (% children) 86.61 12.38 87.09 10.56 91.09 8.71 
Measles immunization (% children) 59.23 9.57 72.67 12.07 86.58 11.19 
Elderly (percentage of population 
over 65 years) 
11.58 2.09 13.09 1.93 14.73 1.64 
Physician density (per 1,000 
population) 
1.58 0.32 2.29 0.45 2.87 0.58 
Doctor visits (per capita) 4.08 1.19 5.39 2.17 6.2 2.55 
GDP per capita (in constant 1995 US 
dollars) 
17,750.94 7,029.03 21,543.59 8,110.65 25,783.31 9,306.90 
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Table 2 
 
Regression estimates from the pooled cross-sectional time series analysis of all-cause 
mortality per 100,000 population 
 
Variables Model 1 
Estimate (S.E.) 
Model 2 Estimate 
(S.E.) 
Model 3 Estimate 
(S.E.) 
Model 4 Estimate 
(S.E.) 
Model 5 Estimate 
(S.E.) 
 
Constant 949.32*** 
(45.75) 
1,256.36*** 
(64.55) 
1,487.51*** 
(80.04) 
1,548.45*** 
(91.38) 
1,491.87*** 
(93.78) 
Tobacco 0.03*** (0.01) 0.03*** (0.01) 0.02** (0.01) 0.01 (0.01) 0.01 (0.01) 
Alcohol 8.59*** (1.49) 8.59*** (1.50) 6.56*** (1.46) 8.03*** (1.46) 8.61*** (1.52) 
Fat consumption  9.44*** (1.66) 9.83*** (1.91) 9.83*** (1.91) 8.46*** (1.96) 
Fruit/vegetable 
consumption 
 -0.20* (0.08) -0.03 (0.09) -0.10 (0.09) -0.19* (0.09) 
Protein consumption  -3.22*** (0.57) -4.25*** (0.70) -3.93*** (0.76) -3.52*** (0.72) 
Air Pollution   0.13 (0.20) 0.46 (0.25) P = 
0.07 
0.48 (0.26) P = 
0.06 
Collective health 
expenditure 
  -72.44*** (18.02) -68.98*** (18.08) -48.95* (19.13) 
Healthcare coverage   -1.89*** (0.30) -1.73*** (0.31) -1.44*** (0.32) 
DTP immunization    -1.39*** (0.31) -1.39*** (0.31) 
Measles 
immunization 
   -0.88** (0.27) -0.88** (0.27) 
Elderly 4.55* (2.26) 1.47 (2.04) 0.60 (2.19) 4.83* (2.19) 4.87* (2.12) 
Physician density -103.65*** (6.34) -47.81*** (7.52) -49.04*** (8.07) -20.57* (8.07) -3.92 (8.74) 
Doctor visits -15.55*** (1.75) -9.57*** (1.70) -4.90** (1.80) -5.31** (1.71) -3.60* (1.68) 
GDP per capita -0.003*** 
(0.0004) 
-0.006*** (0.0005) -0.006*** (0.0005) -0.005*** (0.0005) -0.005*** (0.0005) 
1980s fixed effects++     -60.78*** (9.93) 
1990s fixed effects++     -83.04*** (14.11) 
F change - 38.44# 15.03# 26.57# 17.32# 
Adjusted R2 0.57 0.66 0.79 0.72 0.74 
 
 
S.E.: standard error of estimate; *P < 0.05; **P < 0.01; ***P < 0.001; ++decade time effects to 
eliminate omitted-variable bias due to unobserved heterogeneity with reference to 1970s 
baseline; #significantly better than preceding model and model 1 (P < 0.000); n = 451 
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Table 3 
 
Regression estimates from the pooled cross-sectional time series analysis of all-cause 
potential years of life lost per 100,000 population 
 
Variables Model 1 
Estimate (S.E.) 
Model 2 
Estimate (S.E.) 
Model 3 Estimate 
(S.E.) 
Model 4 
Estimate (S.E.) 
Model 5 Estimate 
(S.E.) 
 
Constant 7,611.05*** 
(489.65) 
9,020.45*** 
(831.22) 
13,168.22*** 
(1,221.73) 
13,906*** 
(869.99) 
13,458.57*** 
(890.95) 
Tobacco 0.27** (0.10) 0.25* (0.10) 0.14* (0.07) 0.01 (0.07) 0.12 (0.07) P = 
0.09 
Alcohol 122.74*** (17.18) 120.99*** (17.65) 87.09*** (17.94) 104.86*** (13.51) 110.26*** (13.59) 
Fat consumption  67.99*** (17.19) 142.39*** (15.96) 102.44*** (15.20) 91.90*** (15.05) 
Fruit/vegetable 
consumption 
 -0.61 (0.85) -3.08** (1.07) -1.09 (0.85) -0.21 (0.84) 
Protein consumption  -14.97* (6.46) -31.04*** (7.02) -22.59*** (6.62) -19.01** (6.38) 
Air Pollution   2.92 (1.8) 7.31*** (2.16) 7.57** (2.30) 
Collective health 
expenditure 
  -1,268.53*** 
(261.88) 
-1,180.31*** 
(162.92) 
-1,002.32*** 
(169.98) 
Healthcare coverage   -36.32*** (5.32) -28.31*** (3.24) -25.37*** (3.30) 
DTP immunization    -21.97*** (3.79) -26.20*** (3.77) 
Measles 
immunization 
   -21.28*** (2.87) -14.53** (2.92) 
Elderly -66.14** (23.54) -103.99*** 
(20.32) 
-70.40*** (19.75) -44.80* (18.88) -47.50** (16.73) 
Physician density -768.98*** 
(72.85) 
-490.75*** 
(88.92) 
-507.20*** (87.45) -41.25 (79.42) -193.32* (89.77) 
Doctor visits -129.19*** 
(17.28) 
-92.20*** (14.28) -10.50 (18.21) -30.13* (14.25) -13.71 (14.28) 
GDP per capita -0.035*** (0.005) -0.052*** (0.006) -0.053*** (0.005) -0.039*** (0.005) -0.04*** (0.005) 
1980s fixed effects++     -656.13*** 
(104.82) 
1990s fixed effects++     -775.84*** 
(141.07) 
F change - 14.02# 36.97# 71.43# 21.89# 
Adjusted R2 0.57 0.60 0.69 0.77 0.79 
 
 
S.E.: standard error of estimate; * P < 0.05; ** P < 0.01; *** P < 0.001; ++decade time effects 
to eliminate omitted-variable bias due to unobserved heterogeneity with reference to 1970s 
baseline; #significantly better than preceding model and model 1 (P < 0.000); n = 451 
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Between 1970 and 1999, all-cause mortality and PYLL decreased on the average by 
approximately 27% and 37% respectively across the selected countries (Table 1). Protein and 
fruit/vegetable consumption increased while alcohol, tobacco, and fat intake decreased, albeit 
with substantial variation across countries. Fat intake actually increased in Greece, Italy, 
Japan, Portugal and Spain by about 0.2 to 2% annually [35]. Immunization levels and 
collective health expenditure also increased. The healthcare coverage levels improved by 
about 2 to 4 percentage points when the United States was excluded from the pool. There 
were also substantial increases in the elderly population, national wealth, density of practicing 
physicians, and doctor visits during the 1970–1999 period. 
 
Table 2 details the regression results for all-cause mortality. Here, tobacco was positively 
associated with all-cause mortality in models 1 to 3, but was not significant in models 4 and 5 
that included immunization variables and time dummies. Alcohol was significantly and 
positively associated with mortality in all the models, yielding mortality increases of 6.6 to 8.6 
per 100,000 populations for every one-liter increase in per capita alcohol consumption. Fat 
consumption also showed a strong positive relationship to mortality in all cases. 
Fruit/vegetable consumption was only negatively related to mortality in the full model and 
when the model excluded environmental, collective health spending, coverage and 
immunizations. Protein showed a stable negative association in all models, changing only 
slightly in model 3. Air pollution was hardly related to mortality in all models that included 
healthcare coverage. Collective health expenditure, healthcare coverage, and immunizations 
were all negatively associated with higher mortality (P < 0.01). 
 
Exclusion of the United States data on healthcare coverage did not substantially alter the 
models, nor did change its association with mortality. Although the total exclusion of the 
healthcare coverage variable did not improve the fit of the models (not reported in Table 2), it 
significantly changed the mortality associations of tobacco, fruit/vegetable consumption, and 
air pollution. Regression coefficients for tobacco changed from 0.02 to 0.06 (P < 0.001) and 
0.01 to 0.02 (P < 0.0) in only models 3 and 4 respectively. For fruit/vegetable consumption, 
the estimates changed from -0.03 to -0.37 (P < 0.001) and -0.10 to -0.25 (P < 0.01) in only 
models 3 and 4 respectively. For air pollution, the estimates changed from 0.13 to 1.40 (P < 
0.001), 0.46 to 0.79 (P < 0.01) and 0.48 to 0.74 (P < 0.01) in models 3, 4 and 5 respectively. 
GDP per capita remained strongly negatively associated with mortality in all models. Except 
for the elderly proportion, all medical input adjustment covariates were significantly associated 
with lower mortality. The total explained variance in all-cause mortality ranged from 57% in 
model 1 to 74% in the fully adjusted model 5. 
 
Table 3 summarizes the corrected fixed effects regression results for age- and sex-
standardized all-cause PYLL, a measure of premature death. Five stepwise 
contemporaneous adjusted models are presented, with each model compared to the 
preceding one and model 1 for improvements. Again, tobacco was significantly associated 
with higher PYLL in all models except those corrected for immunization and time effects. 
Alcohol and fat intake were positively related to higher PYLL. Fruit/vegetable intake was only 
negatively associated with PYLL in model 3 which did not correct for immunization and time 
effects. Air pollution tended to be significantly and positively associated with premature death 
in the fuller models (P < 0.001). Protein, collective health expenditure, healthcare coverage, 
and immunizations all strongly accounted for lower PYLL. As for total all-cause mortality, 
excluding the United States data on healthcare coverage did not substantially alter our 
estimates for factors associated with PYLL. A total exclusion of the healthcare coverage 
variable improved the regression coefficients of air pollution from 2.92 to 20.14 (P < 0.001) in 
model 3, and fruit/vegetable consumption from -0.21 to -2.21 (P < 0.05) in model 5 only. For 
the premature death outcome, the regression coefficients varied more in strength than was 
seen in Table 2 for all-cause mortality. The full, time-adjusted model accounted for 79% of the 
total variance in PYLL in the pooled countries. 
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Discussion  
 
Our contemporaneous, pooled cross-sectional series analysis suggests that a number of 
factors that may be amenable to public health had important associations with mortality and 
premature death in the selected OECD countries during the period 1970 to 1999. Most of 
these associations were still significant even after controlling for demographics, physician 
density, visits to the doctor, and GDP per capita. Tobacco, alcohol and fat intake were all 
positively associated with overall mortality and premature death. Protein consumption, 
collective health expenditure, healthcare coverage, and immunizations exhibited negative 
associations with both outcome measures. Though air pollution did not have significant 
effects on overall mortality, it was sometimes related to higher premature death when other 
covariates were fully taken into account. Fruit/vegetable consumption showed weak and 
inconsistent negative effects on both outcome measures, when partially adjusted for other 
covariates. 
 
Previous studies have showed that some of the factors we studied were important in 
explaining mortality in OECD countries [12,18,20-22,45]. Though tobacco is known to be 
strongly related to higher mortality, our results support other findings that tobacco becomes 
insignificant in fuller models, perhaps suggesting that the tobacco consumption variable is 
poorly defined in the OECD dataset [18,45]. It has been suggested that a better definition 
would be "percent of population that smokes every day," but not the per capita use of tobacco 
we analyzed in this study [18]. Interestingly, in unreported lagged analyses, tobacco only 
became significant in fully adjusted models with at least 5 year-lags. It is, however, unclear 
what this might mean or how to determine what an appropriate lag period would be for all 
covariates in the models. We also found that tobacco was sensitive to adjustments for 
healthcare coverage and time effects in the total all-cause mortality models, suggesting, 
perhaps, that while tobacco consumption variable was limited to specific populations within 
countries, the healthcare coverage variable had a wider reach across populations, effectively 
diluting the statistical effect of tobacco. Similarly, the failure of fruit/vegetable consumption 
and air pollution to show the expected associations [15,16] in the fuller models in this study 
may be due to poor definitions and data quality, or due to their sensitivity to the effect of 
healthcare coverage in the models. 
 
In its 2002 World Health Report, the World Health Organization showed that lifestyle, 
behavioral, and environmental risk factors, such as the ones in this study, accounted for 
significant proportions of the disease and mortality burden in most parts of the world including 
the affluent countries [15]. As much as 39–40% of the disease burden and 51–53% of 
mortality in developed countries were attributable to 20 selected risk factors such as tobacco, 
alcohol, high blood pressure, high body mass index, high cholesterol and low fruit and 
vegetable intake [17]. Our study is the first, however, to report a pooled time series impact of 
tobacco, alcohol, fat, fruit/vegetable, air pollution, collective health expenditure, healthcare 
coverage and immunizations on mortality and premature death, adjusting for demographics, 
medical care input and national wealth in the selected OECD countries during the last 30 
years of the 20th century. It indirectly supports some of the aforementioned population risks, 
but raises questions as to what public health can actually do to curb the unhealthy 
associations. 
 
Revisiting the essential functions of public health [24,46,47] and its classical paradigms of 
health promotion, health protection and disease prevention [14] may offer broad insights into 
holistic approaches for addressing the effects of health determinants. For instance, nutritional 
lifestyle factors are amenable to health promotion [15]. Air pollution could be addressed under 
health protection activities such as environmental modification and regulations. Immunizations 
against infections such as measles, diphtheria, tetanus and pertussis belong to the disease 
prevention role of public health. Although, this study is ecological in nature, uses population 
average variables [48,49], and recognizes the potential for the ecological fallacy [50], it is 
unlikely that the solutions to the problems of, say, alcohol, tobacco, and nutritional lifestyle 
would be entirely ecological. Solutions, such as behavioral modification, targeted at all levels 
of the society, from individuals to groups, would be necessary. 
 
BMC Public Health 2005, 5:81     doi:10.1186/1471-2458-5-81 
 
There is evidence that some countries such as the US [51,52] and the Netherlands [53] have 
ongoing initiatives aimed at tackling health determinants in their populations. It is yet to be 
seen how successful these programs would be if specific attention is not given to re-
engineering public health systems. Increasing healthcare coverage is yet another important 
way of improving population health and its distribution. This is particularly important for the US 
where coverage is still a big problem. 
 
Furthermore, the functions of health status monitoring, surveillance, reducing disaster impact, 
human resource development and public health regulation require substantial investment. 
Public health investment may have increased relative to GDP in many OECD countries, but 
the attained levels and distribution of collective health expenditure are still inadequate, given 
the problems of re-emerging infections, unsolved issues of poverty and inequalities, global 
terrorism and environmental degradation [54]. Currently, many OECD countries spend far 
more on the curative medical care sector [55,56] than on prevention and health promotion 
[35,36]. Unfortunately, many of the diseases (e.g. coronary heart disease) treated in their 
hospitals, for example, tend to arise from such preventable factors as excessive tobacco, fat 
and alcohol use [15-17]. Our study showed that even after adjusting for medical care input, 
there were excess mortality and premature deaths due to preventable factors. 
 
It, therefore, seems prudent to re-focus on public health functions of health systems for at 
least four reasons. First, it averts health problems and minimizes subsequent morbidity and 
mortality. Second, public health faces a legitimacy or relevance problem when it does not deal 
competently with the conflict between civil liberties and health promotion [13], as well as with 
the new 'epidemics' such as obesity [14,57]. Third, the recent attention given to health system 
performance should be more comprehensive and include the optimal functioning of public 
health systems alongside medical care structures [10,11,30,58]. Fortunately, the US, UK, 
Netherlands, Australia and Canada are among the countries actively pursuing systematic 
evaluations of their health systems. Fourth, public policy on health and health-related social 
issues needs to become more integrated, and public health offers an important interface 
between the traditional health sector and the social sectors. There is need for integrated, 
intersectoral and innovative solutions beyond the prevailing narrow policy approaches [57,59]. 
In the light of a similar OECD study that showed that primary care had strong relationship with 
health outcomes [18], even after controlling for similar factors as we studied, it seems that 
strengthening primary care and public health may be a prudent and an effective strategy 
against unfavorable health outcomes. Our study further reinforces recent analyses which 
used the concept of 'avoidable' mortality (that is, mortality that should not occur in the 
presence of effective and timely healthcare) to point out the importance of appropriate public 
health policies as an integral part of evaluating and improving health system performance 
[60,61]. 
 
Limitations of this study 
 
This study used data that may have comparability and definitional deficiencies [20,35,36]. Use 
of secondary data from international resources can import the attendant problems of 
incomparable definitions and poor data quality. The OECD Health dataset (from where we 
took our public health and medical care related variables) and the OECD's Annual National 
Accounts data (that provided the expenditure variables in our study) are no exceptions. There 
are likely issues of errors of observation and comparability in this database given the daunting 
tasks that underlie such international data collection efforts. The incomparability issues are 
even more likely to be more severe as the dataset tries to include more non-healthcare 
accounts measures such as lifestyle factors, as has been the case in recent years. Yet, one 
can be too apologetic about measurement errors in the OECD Health dataset given its 
seeming robustness for routine and political use and for guiding practical decisions so far [62]. 
Besides, efforts are constantly being made to increase the value and quality of the data. 
 
The measures we used are, at best, weak proxies for more robust measures of aggregate 
lifestyle, environmental quality and safety, public health investment and medical care inputs 
[61,63]. Medical care input data tend to show mixed results, especially within the context of 
avoidable mortality [61,64]. Furthermore, this study does not provide clear directions as to 
which policies are best suited for addressing lifestyle, environment, public health investments 
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or any of the factors we studied. The pooled nature of the statistical models limit the potential 
for generalizability of our findings to other countries not included in this study. Moreover, the 
estimated models used crude measures, ignored distributional concerns and distal 
determinants of health, and did not consider the possible multilevel and/or lagged nature of 
the explored relationships. 
 
Conclusion  
 
We have presented a pooled, cross-sectional time series analysis of the associations of 
public health interventions and investment, the environment, and lifestyle-related factors with 
population health in selected industrialized countries during the period 1970–1999. Given the 
limitations of the study, we only make broad-brush assessments of the relevance of these 
findings. In view of current health concerns, our findings serve to make a case for a "new 
public health" as a cornerstone of health systems. As such, health policies aimed at 
preventable factors, namely those modifiable by public health, should count in the overall 
assessment of health systems. 
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